Jon P. Stonehouse, President & CEO at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 14,100 shares at $10.90 ($154K) on 2022-12-15, disclosed to the SEC on 2022-12-19.
Open-market sale of $154k BCRX by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BCRX | SELL | 2022-12-02 | $4.9M | — | Filing → |
| BCRX | SELL | 2022-01-13 | $2.8M | — | Filing → |
| BCRX | SELL | 2020-12-17 | $2.2M | — | Filing → |